Medindia

X

Flextronics Completes SloMedical Acquisition

Wednesday, December 16, 2009 Press Release J E 4
Advertisement


SINGAPORE, Dec. 15 Flextronics (Nasdaq: FLEX) today announced that it has completed the previously announced acquisition of SloMedical S.R.O., a leading European manufacturer of disposable medical devices ranging from tubing sets to complex devices for minimally-invasive surgery. Through its medical segment, Flextronics provides a broad set of capabilities to medical device, medical equipment, and pharmaceutical customers. Terms of the deal were not disclosed.

"The SloMedical acquisition expands our service offering for disposables device manufacturing, specifically in Eastern Europe, and provides Flextronics customers with a geographically advantageous, FDA compliant, high quality, clean room enabled production site with competitive costs," said Dan Croteau, president, Flextronics Medical. "On behalf of Flextronics, I welcome the SloMedical team to Flextronics and look forward to providing our customers with additional product expertise and expanded competitive services."

About Flextronics

Headquartered in Singapore (Singapore Reg. No. 199002645H), Flextronics is a leading Electronics Manufacturing Services (EMS) provider focused on delivering complete design, engineering and manufacturing services to automotive, computing, consumer, industrial, infrastructure, medical and mobile OEMs. Flextronics helps customers design, build, ship, and service electronics products through a network of facilities in 30 countries on four continents. This global presence provides design and engineering solutions that are combined with core electronics manufacturing and logistics services, and vertically integrated with components technologies, to optimize customer operations by lowering costs and reducing time to market. For more information, please visit www.flextronics.com.

SOURCE Flextronics
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Knowledge Networks Expands in Pharma Research With...
S
Department of Health Urges Expanded H1N1 Vaccinati...